HCSGD entry for SPARC
1. General information
Official gene symbol | SPARC |
---|---|
Entrez ID | 6678 |
Gene full name | secreted protein, acidic, cysteine-rich (osteonectin) |
Other gene symbols | ON |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001503 | Ossification | IEA | biological_process |
GO:0002576 | Platelet degranulation | TAS | biological_process |
GO:0005509 | Calcium ion binding | IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005518 | Collagen binding | TAS | molecular_function |
GO:0005576 | Extracellular region | NAS TAS | cellular_component |
GO:0005578 | Proteinaceous extracellular matrix | IEA TAS | cellular_component |
GO:0005604 | Basement membrane | IEA | cellular_component |
GO:0005615 | Extracellular space | IEA | cellular_component |
GO:0005634 | Nucleus | IEA | cellular_component |
GO:0005737 | Cytoplasm | IEA | cellular_component |
GO:0007165 | Signal transduction | IEA | biological_process |
GO:0007507 | Heart development | IEA | biological_process |
GO:0007596 | Blood coagulation | TAS | biological_process |
GO:0009629 | Response to gravity | IEA | biological_process |
GO:0010288 | Response to lead ion | IEA | biological_process |
GO:0030168 | Platelet activation | TAS | biological_process |
GO:0030198 | Extracellular matrix organization | TAS | biological_process |
GO:0030324 | Lung development | IEA | biological_process |
GO:0031012 | Extracellular matrix | IEA | cellular_component |
GO:0031093 | Platelet alpha granule lumen | TAS | cellular_component |
GO:0031988 | Membrane-bounded vesicle | IEA | cellular_component |
GO:0032496 | Response to lipopolysaccharide | IEA | biological_process |
GO:0033591 | Response to L-ascorbic acid | IEA | biological_process |
GO:0034097 | Response to cytokine | IEA | biological_process |
GO:0042060 | Wound healing | IEA | biological_process |
GO:0042127 | Regulation of cell proliferation | IEA | biological_process |
GO:0043434 | Response to peptide hormone | IEA | biological_process |
GO:0045471 | Response to ethanol | IEA | biological_process |
GO:0046686 | Response to cadmium ion | IEA | biological_process |
GO:0048839 | Inner ear development | IEA | biological_process |
GO:0050840 | Extracellular matrix binding | IEA | molecular_function |
GO:0051384 | Response to glucocorticoid | IEA | biological_process |
GO:0051591 | Response to cAMP | IEA | biological_process |
GO:0051592 | Response to calcium ion | IEA | biological_process |
GO:0060348 | Bone development | IEA | biological_process |
GO:0071363 | Cellular response to growth factor stimulus | IEA | biological_process |
GO:0071682 | Endocytic vesicle lumen | TAS | cellular_component |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.8701329471 | 0.0096798792 | 0.9999902473 | 0.1948280153 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.2669025292 |
GSE13712_SHEAR | Down | -0.2469602543 |
GSE13712_STATIC | Down | -0.2574651501 |
GSE19018 | Up | 0.5894224318 |
GSE19899_A1 | Down | -0.8072735163 |
GSE19899_A2 | Down | -1.1153489765 |
PubMed_21979375_A1 | Down | -2.3461774666 |
PubMed_21979375_A2 | Down | -1.1166941820 |
GSE35957 | Up | 0.4506971716 |
GSE36640 | Up | 0.4422575539 |
GSE54402 | Down | -1.1710119783 |
GSE9593 | Up | 0.3400748429 |
GSE43922 | Down | -0.2327033078 |
GSE24585 | Up | 0.3107277703 |
GSE37065 | Down | -0.2372397478 |
GSE28863_A1 | Down | -0.0446219686 |
GSE28863_A2 | Down | -0.1019620436 |
GSE28863_A3 | Up | 0.0686873342 |
GSE28863_A4 | Down | -0.3436961592 |
GSE48662 | Down | -0.0315432689 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-29c-3p | MIMAT0000681 | MIRT001922 | Luciferase reporter assay//Reporter assay;Other | Functional MTI | 18390668 |
hsa-miR-29a-3p | MIMAT0000086 | MIRT006175 | qRT-PCR | Functional MTI (Weak) | 22864815 |
hsa-miR-192-5p | MIMAT0000222 | MIRT004126 | Microarray | Functional MTI (Weak) | 16822819 |
hsa-miR-10a-5p | MIMAT0000253 | MIRT047698 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-29a-3p | MIMAT0000086 | NA | hsa-miR-29a | 18390668 | |||
hsa-miR-204-5p | MIMAT0000265 | NA | hsa-miR-204 | 20369013 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 8 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
20554622 | Levels of apolipoprotein J (Apo J), SM22, and osteonectin (SPARC) mRNA were determined by real-time PCR analysis |
20554622 | RESULTS: TGF-beta2 increased SA-beta-Gal activity, lipid peroxidation, and the mRNA expressions of Apo J, SM22, and SPARC |
20164124 | We previously revealed that secreted protein acidic and rich in cysteine (SPARC), a matricellular protein, may function as a modulator of chemotherapy sensitivity by enhancing apoptosis |
20164124 | However, CPT-11-resistant cells exposed to endogenous or exogenous SPARC can also be triggered into cellular senescence |
20164124 | Knock down of p16(INK4A) reduces drug-induced senescence in all cells, but knock down and overexpression of p53 modulates senescence only in cells exposed to SPARC |
20164124 | Furthermore, treatment of mice with SPARC and CPT-11 leads to significantly increased cellular senescence and tumor regression |
20164124 | The chemosensitizing effects of SPARC in CRCs are, therefore, probably mediated in part by activating cellular senescence |
18425358 | Thirdly, the mRNA levels of three senescence-associated genes, fibronectin, osteonectin and SM22, also increased |
16893911 | The impaired osteoblast differentiation in Nf1+/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin |
11060295 | In this work, we show that transforming growth factor-beta1 (TGF-beta1) regulates the induction of several of these biomarkers in SIPS: cellular morphology, senescence-associated beta-galactosidase activity, increase in the steady-state level of fibronectin, apolipoprotein J, osteonectin, and SM22 mRNA |
11060295 | In the presence of each of these antibodies, the steady-state level of fibronectin, osteonectin, apolipoprotein J, and SM22 mRNA is no more increased at 72 h after stress |
10958924 | Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells |
10958924 | Secreted protein, acidic and rich in cysteine (SPARC) has been suggested to play an important role in wound repair and mineralization |
10958924 | Levels of SPARC mRNA in HPL cells increased with cellular ageing in vivo |
10958924 | The changes in proliferative ability and the mRNA levels of SPARC and OPG/OCIF with cellular ageing in vitro were similar to those with ageing in vivo |
10958924 | Furthermore, the increase in SPARC with ageing may be related to changes in metabolism of periodontal ligament that occur with ageing |
9570922 | Construction of cDNA libraries from two conditional cell lines and application of differential screening and subtractive hybridization techniques have resulted in the cloning of eight senescence-induced genes (SGP-2/Apo J, alpha 1-procollagen, osteonectin, fibronectin, SM22, cytochrome C oxidase, GTP-alpha, and a novel gene) and a senescence-repressed gene (FRS-2) |
9080393 | Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts |
9080393 | The RNA species encoded by IGFBP-3 (insulin-like growth factor binding protein-3), PAI-1 (plasminogen activator inhibitor-1) and SPARC (secreted protein-acidic and rich in cysteine; a |
9080393 | Characterization of the rates of transcription and the levels of message stability of these genes in early passage (young) versus late passage (old) HDF revealed that IGFBP-3, PAI-1 and SPARC are coordinately overexpressed but not regulated by a unique or simple mechanism encompassing all three transcripts |
Entries Per Page
Displaying Page of